Regulation of Staphylococcus aureus-induced CXCR1 expression via inhibition of receptor mobilization and receptor shedding during dual receptor (TNFR1 and IL-1R) neutralization.


Journal

Immunologic research
ISSN: 1559-0755
Titre abrégé: Immunol Res
Pays: United States
ID NLM: 8611087

Informations de publication

Date de publication:
06 2019
Historique:
pubmed: 11 7 2019
medline: 6 2 2020
entrez: 11 7 2019
Statut: ppublish

Résumé

Our earlier studies proposed a radically new idea suggesting interdependency between TNF-α/TNFR1 and IL-1β/IL-1R pathways in modulation of Staphylococcus aureus-induced CXCL8/CXCR1 axis. However, the effects of inhibition of cytokine receptor mobilization at intracellular level and surface TNFR1 and IL-1R shedding on S. aureus-induced CXCR1 expression have not been studied so far in peritoneal macrophages. This study aimed to investigate the role of inhibition of receptor mobilization from the intracellular pool (using brefeldin A) and surface receptor shedding (using TAPI-1) on CXCR1 expression during dual receptor (TNFR1 plus IL-1R) neutralization in peritoneal macrophages isolated from wild-type Swiss Albino mice. Release of superoxide anion, nitric oxide, and hydrogen peroxide was measured and cytokine production was done by ELISA. Expression of surface receptors (TNFR1, IL-1R, and CXCR1) and inflammatory mediators was studied by Western blot. It was observed that S. aureus-infected macrophages showed elevated ROS production, secretion of TNF-α, IL-1β, and CXCL8, along with increased expression of surface receptors (TNFR1, IL-1R, and CXCR1), and inflammatory markers (iNOS and COX-2) compared with control or treated groups (p < 0.05). However, prior treatment of macrophages with BFA or TAPI-1 in the presence of anti-TNFR1 antibody and IRAP during S. aureus infection showed significant reduction of all these parameters (p < 0.05). We can conclude that targeting of TNFR1 and IL-1R (with major focus on surface expression study) either through blockage of intracellular receptor trafficking pathway or via surface receptor shedding diminishes TNFR1/IL-1R interaction and consequently downregulates CXCR1 expression along with inflammatory signalling pathways during bacterial infections.

Identifiants

pubmed: 31290001
doi: 10.1007/s12026-019-09083-x
pii: 10.1007/s12026-019-09083-x
doi:

Substances chimiques

Biomarkers 0
Cytokines 0
Receptors, Interleukin-1 Type I 0
Receptors, Interleukin-8A 0
Receptors, Tumor Necrosis Factor, Type I 0
Nitric Oxide 31C4KY9ESH
Hydrogen Peroxide BBX060AN9V

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

241-260

Références

J Immunol. 2007 Apr 15;178(8):4917-25
pubmed: 17404273
J Invest Dermatol. 2010 Jul;130(7):1866-76
pubmed: 20182449
PLoS One. 2015 Oct 16;10(10):e0140942
pubmed: 26474296
Arthritis Rheumatol. 2014 Oct;66(10):2728-38
pubmed: 24965881
Front Immunol. 2015 May 19;6:225
pubmed: 26042120
Cardiovasc Res. 2009 Oct 1;84(1):137-44
pubmed: 19482949
Methods Enzymol. 1986;132:95-180
pubmed: 3821529
Clin Infect Dis. 2008 Jun 1;46 Suppl 5:S350-9
pubmed: 18462090
Science. 1998 Nov 13;282(5392):1281-4
pubmed: 9812885
Immunol Lett. 2017 Oct;190:93-107
pubmed: 28736159
Microb Pathog. 2017 Dec;113:460-471
pubmed: 29162483
J Biol Chem. 2003 Jun 13;278(24):21751-60
pubmed: 12646554
J Biol Chem. 1995 Dec 15;270(50):30199-204
pubmed: 8530430
Curr Top Microbiol Immunol. 2016;397:257-82
pubmed: 27460814
Invest Ophthalmol Vis Sci. 2009 Oct;50(10):4618-21
pubmed: 19407014
Blood. 2012 Jan 19;119(3):651-65
pubmed: 22053109
Nature. 1996 Nov 7;384(6604):23-4
pubmed: 8900268
Immunology. 2013 Aug;139(4):503-12
pubmed: 23489296
J Biol Chem. 2000 May 12;275(19):14608-14
pubmed: 10799547
J Immunol. 2005 Aug 1;175(3):1930-6
pubmed: 16034137
Biochem J. 2002 Aug 15;366(Pt 1):15-22
pubmed: 11985495
Microb Pathog. 2017 Aug;109:131-150
pubmed: 28552636
J Biol Chem. 1988 Dec 5;263(34):18545-52
pubmed: 3192548
Theranostics. 2017 Apr 7;7(6):1543-1588
pubmed: 28529637
J Exp Med. 1988 Jun 1;167(6):1883-93
pubmed: 3260265
Curr Opin Cell Biol. 2016 Apr;39:21-7
pubmed: 26872272
Oxid Med Cell Longev. 2017;2017:4123854
pubmed: 28280524
Clin J Am Soc Nephrol. 2008 Mar;3(2):397-406
pubmed: 18235145
J Immunol. 2013 Apr 15;190(8):4196-204
pubmed: 23487424
Am J Respir Cell Mol Biol. 1999 Sep;21(3):388-94
pubmed: 10460756
Clin Cancer Res. 2001 Jun;7(6):1812-20
pubmed: 11410524
Pulm Pharmacol Ther. 2008 Aug;21(4):675-81
pubmed: 18515164
Biochem Biophys Res Commun. 2002 Jun 14;294(3):642-9
pubmed: 12056817
J Innate Immun. 2016;8(3):284-98
pubmed: 26967533
J Interferon Cytokine Res. 2009 May;29(5):273-84
pubmed: 19231998
J Biol Chem. 2007 Apr 20;282(16):11658-66
pubmed: 17197447
Osteoarthritis Cartilage. 1999 Jul;7(4):367-70
pubmed: 10419769
Cell Logist. 2014 Jan 1;4(1):e27732
pubmed: 24843827
Mol Pharmacol. 2001 Oct;60(4):646-55
pubmed: 11562425
BMC Immunol. 2013 Feb 05;14:6
pubmed: 23384230
Proc Natl Acad Sci U S A. 2005 Mar 15;102(11):4022-6
pubmed: 15753287
PLoS One. 2013 Sep 13;8(9):e74287
pubmed: 24058538
Sci Signal. 2015 Jan 27;8(361):ra11
pubmed: 25628461
J Cell Biol. 1995 Dec;131(6 Pt 2):1715-26
pubmed: 8557739
J Interferon Cytokine Res. 1999 May;19(5):429-38
pubmed: 10386854
Semin Immunol. 2013 Dec 15;25(6):394-407
pubmed: 24246227
J Biol Chem. 2011 Oct 14;286(41):35466-76
pubmed: 21865167
Nat Rev Drug Discov. 2013 Feb;12(2):147-68
pubmed: 23334208
J Biol Chem. 2011 Sep 9;286(36):31308-19
pubmed: 21775438
Proc Natl Acad Sci U S A. 2009 Mar 10;106(10):4018-23
pubmed: 19234125
Adv Exp Med Biol. 1993;351:87-97
pubmed: 7942301
Crit Rev Eukaryot Gene Expr. 2010;20(2):87-103
pubmed: 21133840
Front Cell Infect Microbiol. 2013 Jan 04;2:167
pubmed: 23316483
Br J Pharmacol. 1999 Feb;126(3):810-8
pubmed: 10188995
J Exp Med. 2004 Aug 2;200(3):367-76
pubmed: 15289505
J Biol Chem. 1951 Nov;193(1):265-75
pubmed: 14907713
Infect Immun. 2012 Mar;80(3):1140-9
pubmed: 22158745
J Biol Chem. 1993 Feb 15;268(5):3677-82
pubmed: 8429043
Infect Immun. 1997 Sep;65(9):3889-95
pubmed: 9284168
Am J Respir Cell Mol Biol. 1999 Jan;20(1):122-8
pubmed: 9870925

Auteurs

Puja Dutta (P)

Department of Physiology, Immunology Laboratory, University of Calcutta, University Colleges of Science and Technology, 92 APC Road, Calcutta, West Bengal, 700009, India.

Sahin Sultana (S)

Department of Physiology, Immunology Laboratory, University of Calcutta, University Colleges of Science and Technology, 92 APC Road, Calcutta, West Bengal, 700009, India.

Rajen Dey (R)

Department of Physiology, Immunology Laboratory, University of Calcutta, University Colleges of Science and Technology, 92 APC Road, Calcutta, West Bengal, 700009, India.

Biswadev Bishayi (B)

Department of Physiology, Immunology Laboratory, University of Calcutta, University Colleges of Science and Technology, 92 APC Road, Calcutta, West Bengal, 700009, India. biswadevbishayi4@gmail.com.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH